Literature DB >> 789248

Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.

L A Hodgin, J Drews.   

Abstract

The capacity of lipid A, a structure common to the lipopolysaccharide cores of all gram-negative bacteria, to serve as an active immunizing agent in mice and to protect these animals against gram-negative infections was investigated. Active immunization experiments were also performed with the Re mutant of Salmonella minnesota 595 which carries a lipopolysaccharide composed of lipid A and three residues of ketodeoxyoctonic acid. Single injections of lipid A complexed to acid-hydrolyzed bacteria as carriers failed to induce specific protection against subsequent challenge infections with E. coli O4 and S. breslau. Repeated injections of lipid A resulted in good protection against intraperitoneal challenge with S. breslau and partial protection against intravenous challenge with the same organism but did not alter the sensitivity of mice to challenge infections with E. coli or Pasteurella multocida. Whole antisera or serum fractions from rabbits in which high titers against lipid A had been attained by repeated intravenous injections of the antigen did not protect mice against challenge infections with E. coli O4. In contrast a single injection of the Re mutant of S. minnesota antigen in combination with incomplete Freund's adjuvant provided substantial protection against an otherwise lethal intraperitoneal infection with S. breslau over a period of at least 45 days. Repeated application of the Re antigen resulted in partial protection against experimental infections with E. coli O4, S. breslau and Pasteurella multocida. Injections of S. minnesota Re 595 antiserum provided better protection against an E. coli O4 infection than lipid A sera or antibodies of the IgG or IgM type directed against this antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789248     DOI: 10.1007/bf01638340

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Investigations on the mechanism of stimulation of non-specific immunity by bacterial lipopolysaccharides.

Authors:  J G HOWARD; D ROWLEY; A C WARDLAW
Journal:  Immunology       Date:  1958-07       Impact factor: 7.397

2.  Macromolecular structure of lipopolysaccharides from gram-negative bacteria.

Authors:  E Hannecart-Pokorni; D Dekegel; F Depuydt
Journal:  Eur J Biochem       Date:  1973-09-21

3.  Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595.

Authors:  N A Mullan; P M Newsome; P G Cunnington; G H Palmer; M E Wilson
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

4.  Type-specific and cross-reactive antibodies in gram-negative bacteremia.

Authors:  W R McCabe; B E Kreger; M Johns
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

5.  Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides.

Authors:  E T Rietschel; H Gottert; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1972-07-13

6.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

7.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

8.  Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-12-22

9.  Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli.

Authors:  W R McCabe; A Greely
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  SEPARATION, CHARACTERIZATION, AND BIOLOGICAL SIGNIFICANCE OF A COMMON ANTIGEN IN ENTEROBACTERIACEAE.

Authors:  C M KUNIN
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.

Authors:  M Trautmann; H Hahn
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

2.  Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.

Authors:  B J Appelmelk; A M Verwey-van Vught; J J Maaskant; W F Schouten; L G Thijs; D M Maclaren
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.